SCN5A and breast cancer: Abnormal activation and expression of Nav1.5 can trigger various cellular mechanisms, including altering H+ efflux, promoting epithelial-mesenchymal transition, and enhancing the expression of cysteine proteases, to increase the invasive and metastatic abilities of BC cells in vitro and in vivo (Luo et al., 2020).